Table 1 The characteristics of patients and tumors [M (QL, QU)/n (%)]†
Variables | Total |
|---|---|
Age (years) | 66 (60, 72) |
Radiotherapy time (o’clock) | 14(9,18) |
Tumor length in gastroscope (cm) | 5(4, 6) |
PGTV dose (Gy) | 59.4(59.4, 61.6) |
PGTV fractionation (times) | 28(28, 30) |
PTV dose (Gy) | 50.4(50.4, 50.4) |
PTV fractionation (times) | 28(28, 28) |
Age (years) | |
< 69 | 290(59.4) |
≥ 69 | 198(40.6) |
Radiotherapy time | |
Before 19:00 | 369(75.6) |
After 19:00 | 119(24.4) |
Tumor length in gastroscope (cm) | |
< 5 | 160(32.8) |
≥ 5 | 328(67.2) |
PGTV dose (Gy) | |
< 59.4 | 113(23.2) |
≥ 59.4 | 375(76.8) |
PGTV fractionation (times) | |
< 33 | 448(91.8) |
≥ 33 | 40(8.2) |
PTV dose (Gy) | |
< 54.19 | 116(23.8) |
≥ 54.20 | 372(76.2) |
PTV fractionation (times) | |
< 28 | 119(24.4) |
≥ 28 | 369(75.6) |
Single-fraction dose (Gy) | |
1.8 and 2.0 | 192(39.3) |
2.12 and 2.2 | 296(60.7) |
Gender | |
Male | 367(75.2) |
Female | 121(24.8) |
PS | |
0–1 | 367(75.2) |
2 | 121(24.8) |
Dysphagia | |
Yes | 364(74.6) |
No | 124(25.4) |
T stage | |
1–2 | 103(21.1) |
3–4 | 385(78.9) |
N stage | |
0–1 | 386(79.1) |
2–3 | 102(20.9) |
Clinical stage | |
I-II | 101(20.7) |
III | 326(66.8) |
IV | 61(12.5) |
Main tumor location | |
Lower thoracic | 181(37.1) |
Middle thoracic | 179(36.7) |
Cervical segment + Upper thoracic | 128(26.2) |